Hox

HoX (HoX Inc.) develops integrated hardware and software systems intended to automate operations across the bioeconomy, which the company describes as "Biology Computers" that link sample handling, sequencing, data management and analysis into a single platform. Its offering spans three areas: sample-to-exploration sequencing services delivered through what it calls elastic sequencing centers; workflow and analysis applications for multimodal biological data built over one standardized data model; and full-stack, vertical-specific products.

The platform, referred to as the HoX Operating System, includes a control plane for the lab: a multimodal linked-data layer that AI coding agents (protocol, QC, analysis and pipeline agents) can query directly from a terminal, with fully indexed backend storage, scoped sessions, governed access and an audit log so actions are traceable. The company describes a four-layer data stack comprising an application layer of installable capability modules, a domain layer of sector-specific semantic types and functions, a columnar warehouse with disaggregated compute and storage, and hyper-scale blob storage. A core structure called the resource graph encodes relationships between data objects (for example patient to samples to libraries to sequencing reads), grows as operational processes run, and can be queried through HoX Query Language (HQL), with single-experiment tables expanded into cross-repository virtual tables for population-scale and longitudinal analysis.

Because the stack is vertically integrated, HoX packages it as self-contained server appliances at sizes ranging from small form factors to rack-scale and exascale clusters, deployable in its own data centers or the customer's, including fully private deployments that function without internet access. Multiple deployments across geographic and institutional boundaries federate into what the company calls a Biological Information Network (BIN), a shared substrate giving a common operating picture and interoperability across sites, agencies and partners.

Founding story

HoX was cofounded by James van Alstine (CEO) and Phil Hofer (CTO). Van Alstine was previously the first engineer at MyOme and before that at Genomic Prediction, with nearly a decade in scientific computing; Hofer was previously CTO of Sneller, a log analysis engine, with a decade of experience in performance engineering, compiler design, SIMD and storage systems. The company frames its motivation as making biological capability operational in everyday life and business, addressing fragmentation and data scarcity in biological information.

Business model

HoX sells services and deployable systems rather than a single product: sequencing and laboratory services where customers submit samples and receive a built system of record, software application modules that install on the platform, and packaged appliances or data-center deployments of the HoX Operating System. For precision medicine (SPLICE) it offers three operating models — in-house, where it equips the customer's lab to run the full stack on site; hybrid, where HoX runs selected steps while workflows and custody remain with the customer; and send-out, where HoX's own lab runs the test and returns raw data and evidence into the customer's environment. It also works under government contracts, including a pilot contract with Lawrence Livermore National Laboratory.

Revenue sources indicated include laboratory and sequencing services, software applications and assay catalog items switched on as needed, deployed appliances and infrastructure, and government pilot contracts.

Traction

In January 2026 HoX publicly announced the company together with a $2 million pilot contract with Lawrence Livermore National Laboratory, backed by the Department of War's Chemical and Biological Defense Program, to establish a next-generation biodefense system for detecting emerging biological threats. The company stated it had spent the prior two years building its system.